MEDIMI AB AK
Servana AB engages in the digital development business. The company was formerly known as Medimi AB. Servana AB is based in Lund, Sweden. Servana AB operates as a subsidiary of PixelFox Group AB.
MEDIMI AB AK (79T) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MEDIMI AB AK (79T) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MEDIMI AB AK - Net Assets Trend (None–None)
This chart illustrates how MEDIMI AB AK's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDIMI AB AK (None–None)
The table below shows the annual net assets of MEDIMI AB AK from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MEDIMI AB AK's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MEDIMI AB AK Competitors by Market Cap
The table below lists competitors of MEDIMI AB AK ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Protagenic Therapeutics
NASDAQ:PTIX
|
$341.67K |
|
Transforma Resources Corp
V:TFM
|
$341.87K |
|
NATURENERGIE
SW:NEAG
|
$341.92K |
|
Composite Alliance Group Inc
V:CAG
|
$341.97K |
|
Medicine Man Technologies Inc
PINK:SHWZ
|
$341.36K |
|
enX Group Ltd
JSE:ENX
|
$341.21K |
|
OSAKA GAS - Dusseldorf Stock Exchang
DU:OSA
|
$341.02K |
|
WAERTSILAE
MU:MTA
|
$340.76K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDIMI AB AK's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MEDIMI AB AK's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDIMI AB AK utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MEDIMI AB AK's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDIMI AB AK (79T) | €- | N/A | N/A | $341.57K |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $213.74 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $475.06 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $32.92 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $217.64 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $658.78 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $783.58 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.63 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.27 Billion |